PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Israeli Health Ministry slammed for 'dragging feet' on new HIV drug

    Israel Hayom reveals content of sharp letter sent by medical, community associations to Health Ministry accusing it of endangering public health by delaying introduction of new treatment to prevent HIV infection.

    05 December 2016 | Israel Hayom
  • Response to NHS England announcement on PrEP

    We are disappointed that PrEP will not be available on the NHS in the near future. Nonetheless, we are glad that at least 10,000 people will be offered PrEP... We hope that the trial will build on evidence from PROUD, instead of merely repeating the important work that has already been completed.

    05 December 2016 | PROUD study
  • PrEP in the UK: Terms and Conditions will apply

    The commitment to provide PrEP on the NHS was long overdue, but the proposed mode of delivery raises more questions than it provides answers.

    05 December 2016 | Incidence 0
  • Questions about the PrEP implementation study

    It’s a start. It’s not ideal but it’s a start.

    05 December 2016 | Greg Owen (blog)
  • NHS England fudges PrEP access and delays on-demand access to PrEP by years; blocks doctors from prescribing PrEP now

    It is difficult to be impressed with this compromise. Rather than meet the real need of people currently at highest risk, it will further delay access to an option to prevent HIV transmission that has clearly passed the criteria for safety, efficacy and effectiveness laid out for other NHS treatments.

    04 December 2016 | HIV i-Base
  • PrEP: Australian advocates call for greater affordability and access to new preventative HIV method

    Truvada is already listed under the pharmaceutical benefits scheme for use to treat people with HIV, but is not available for prevention. "We are incredibly keen to see this available through the PBS at scale quickly, very, very quickly," Darryl O'Donnell, CEO of the Australian Federation of AIDS Organisations said.

    02 December 2016 | ABC
  • MP calls for PrEP manufacturer to submit to Scottish regulator

    The Scottish Medicines Consortium is responsible for approving all drugs available on the NHS in Scotland and the Glasgow South MP has called for the company to make a submission, so it can form part of the country’s HIV prevention strategy.

    02 December 2016 | Pink News
  • Switching course, Gilead markets HIV drug for prevention

    This fall, the drugmaker began marketing directly to consumers with print advertisements in publications geared toward the lesbian, gay, bisexual and transgender community, including OUT, Advocate and SWERV. It plans soon to expand to social media and digital.

    30 November 2016 | Reuters
  • Jake Sobo: My life on PrEP—4 years later

    We couldn’t be more excited to re-connect with one of our legendary contributors, Jake Sobo, for this feature on BETA. Back in 2012, Sobo was one of the first—if not the first—gay man to write openly about his experience taking PrEP for HIV prevention. He quickly became one of our most read and controversial authors—sparking debates online and off. We recently caught up with Jake to get an update on his life, hear his thoughts on the future of PrEP, and find out what he thinks about rising rates of sexually transmitted infections among gay men.

    30 November 2016 | BETA blog
  • Argument over funding HIV PrEP drug reveals reluctance to tackle the realities of gay sex

    Ignoring those at 'high risk' of HIV in order to sustain the idea of the 'good' gay man will only perpetuate the virus.

    22 November 2016 | The Independent
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.